ResMed Inc. (RMD) Stock Price Today
Aura AI Summary
Key Stats
- $33.69BMarket Cap
- 836,359Volume
- HealthSector
- $275.9652W High
- $182.8252W Low
- 52 DaysTypical Hold Time
- $33.29BEnterprise Value
- 1.1%Div Yield
- -Trading Activity
Track ResMed Inc. (RMD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ResMed Inc. has traded between a low of $182.82 and a high of $275.96, highlighting its annual price range. Buy and sell ResMed Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Most Recent News
All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects
Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...
IDEAYA nominates IDE101, a novel dual CDK inhibitor targeting CDKN2A-deficient tumors, aiming for FDA filing in H1 2027.
IDEAYA Biosciences announced IDE101 as a new development candidate designed to treat tumors with CDKN2A deficiency, common in 10-15% of solid tumors including 70% of pancreatic cancers. IDE101 is a first-in-class dual cyclin-dependent kinase inhibito...
Widows filing Social Security benefits in the wrong order lose up to $56,000 over a lifetime.
A 63-year-old widow with a $900,000 IRA lost about $56,000 by claiming her larger Social Security survivor benefit first instead of her smaller retirement benefit. The Social Security Administration's audit found many widows could gain an average of ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.